Form 4: Acumen Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Derek M. Meisner, Chief Legal Officer & Corp Sec of Acumen Pharmaceuticals, sold 3,418 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• On January 21, 2025, Derek M. Meisner, Chief Legal Officer & Corp Sec of Acumen Pharmaceuticals, sold 3,418 shares of common stock.
• The sale was executed at a price of $1.59 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on May 15, 2024.
• The sale was to cover tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, Meisner directly owns 161,127 shares of Acumen Pharmaceuticals.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Sales of shares to cover tax obligations are a common practice among corporate executives, especially when dealing with vesting of restricted stock units. These sales are often pre-planned under Rule 10b5-1 trading plans to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact given the reason for the sale and the relatively small number of shares involved.

Key Dates

Keywords

Acumen Pharmaceuticals, ABOS, Form 4, Insider Trading, Stock Sale, Derek Meisner, Rule 10b5-1, Tax Obligations, Restricted Stock Units